ARA 284
/ Araim
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
June 26, 2026
Combination Therapy with Bisoprolol and Tissue Protective Molecule ARA 284 Is Cardio-Protective and Improves Survival in Experimental Cancer Cachexia.
(PubMed, J Cardiovasc Dev Dis)
- "Our findings show that the combination of bisoprolol and ARA 284 is beneficial in a hepatoma cachexia model and may provide greater overall effects than either monotherapy alone."
Journal • Cachexia • Hepatocellular Cancer • Liver Cancer • Oncology • Solid Tumor
1 to 1
Of
1
Go to page
1